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Abstract
Purpose Calcium supplements are prescribed for preven-
tion of osteoporotic fractures, but there is controversy
whether excess of calcium intake is associated with car-
diovascular events. While an accurate estimation of dietary
calcium intake is a prerequisite to prescribe the adequate
amount of supplementation, the most adequate tools for
estimating intake are time-consuming. The aim of this
study is to validate a short calcium intake list (SCaIL) that
is feasible in daily clinical practice.
Methods Based on the food groups contributing most to
daily dietary calcium intake and portion sizes determined
in an earlier study, a three-item, 1-min SCaIL was
designed. As a reference method, an extensive dietary
history (DH) with specific focus on calcium-rich foods and
extra attention for portion sizes was performed. Before-
hand, a difference of C250 mg calcium between both
methods was considered clinically relevant.
Results Sixty-six patients with either primary (n = 40) or
secondary (n = 26) osteoporosiswere included.On average,
the SCaIL showed a small and clinically non-relevant dif-
ference in calcium intake with the DH: 24 ± 350 mg/day
(1146 ± 440 vs. 1170 ± 485 mg, respectively; p = 0.568).
Sensitivity and specificity of the SCaIL, compared to theDH,
were 73 and 80%, respectively. However, in 50% of the
individuals, a clinically relevant difference of C250 mg
calcium was observed between both methods, while in 17%
this was even C500 mg.
Conclusions The SCaIL is a quick and easy questionnaire to
estimate dietary calcium intake at a group level, but is not
sufficiently reliable for use in individual patients. Remark-
ably, themean dietary calcium intake estimated by theDHof
1170 mg/day indicates that a large proportion of osteo-
porosis patients might not even need calcium supplementa-
tion, although more data are needed to confirm this finding.
Keywords Calcium  Dietary history  Osteoporosis 
Questionnaire  Supplementation  Validation
Introduction
Calcium supplements are frequently prescribed for the
prevention of osteoporotic fractures. However, the recent
literature suggests that too much calcium supplementation
may be associated with cardiovascular events. A five-year
randomized controlled trial [1] and two meta-analyses
[2, 3] of Bolland et al. demonstrated that use of calcium
supplements was associated with an increased risk of car-
diovascular events. In these studies, 500 mg/day of cal-
cium or more was administered to the participants in the
intervention group and a placebo to the control group, with
a background intake of dietary calcium of around
850 mg/day. Also Li et al. [4], Pentti et al. [5] and
Anderson et al. [6] found an increased risk of myocardial
infarctions, coronary heart disease and coronary artery
calcification, respectively, among users of calcium sup-
plements. In contrast to these studies, Lewis et al. [7] found
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no evidence that calcium supplements were associated with
an increased risk of cardiovascular disease after adminis-
trating 1200 mg/day of calcium or identical placebo
tablets, next to a mean intake of around 950 mg of dietary
calcium. Also in their meta-analysis from 2015, they did
not found evidence that calcium supplementation with or
without vitamin D increases the risk of coronary heart
disease in elderly women [8], as did Paik et al. [9].
Although the literature is still inconsistent and incon-
clusive about the association between calcium supplements
and cardiovascular events [10], the supposed cardiovascu-
lar side effects are frequently debated by health profes-
sionals as well as by patients. Since optimal calcium intake
is crucial in the prevention and treatment of osteoporosis,
calcium supplements are prescribed to patients with an
insufficient dietary intake of calcium. According to
national [11] and international [12–14] guidelines, the
Recommended Dietary Allowances (RDA) of calcium is
1000–1200 mg/day for patients with osteoporosis. An
accurate estimation of dietary calcium intake is necessary
to adequately prescribe calcium supplements up to the
recommended intake.
Several food frequency questionnaires (FFQs) for esti-
mating dietary calcium intake have been designed for
patients with osteoporosis specifically and validated in the
last decennium [15–17]. However, for accurate estimation
by physicians, and as a basis for adequate prescriptions,
these FFQs are too time-consuming. To our knowledge, no
short questionnaire for a reliable estimation of dietary
calcium intake of osteoporosis patients by physicians is
available. Our group has recently shown that an existing
calcium intake list with three items is not a valid method to
estimate calcium intake of osteoporosis patients [18]. Since
we are in search of an easy, accurate and feasible method to
estimate calcium intake of osteoporosis patients, we
developed a new short, quick and easy calcium intake list
that can be used by physicians to estimate dietary calcium
intake of patients with osteoporosis validly in less than two
minutes, in order to prescribe adequate amounts of calcium
supplements to the patient.
The aim of this study is to validate this short calcium
intake list (SCaIL) with an extensive dietary history (DH)
as a reference method, to accurately estimate dietary cal-




This descriptive cross-sectional study included consecutive
patients attending the outpatient rheumatology department
of the Amsterdam Rheumatology and Immunology Center,
location VU University Medical Center in Amsterdam, the
Netherlands, for the treatment of primary or secondary
osteoporosis. Patients were recruited between March and
December 2013. Inclusion criteria for this study were: age
of 18 years or older at inclusion and treatment with anti-
osteoporosis agents by a rheumatologist. In addition,
patients with secondary osteoporosis had to be diagnosed
with a rheumatic disorder by a rheumatologist. Pregnant
women, cognitively impaired persons or patients who do




The SCaIL is a short calcium intake list in which the
patients are asked how many servings of dairy products
they consume on a regular day (Fig. 1). The SCaIL was
designed according to the main contributors to the daily
dietary calcium intake using the outcomes of the Dutch
National Food Consumption Survey 2007–2010 of the
National Institute of Public Health and the Environment
(RIVM) [19]. With the Dutch FFQ tool [20], the main
contributors of calcium intake of a subgroup of Dutch
adults aged 55–69 years were determined: (butter)milk and
other dairy drinks (22.0%); yoghurt, quark, custard, pud-
ding and porridge (12.8%); and cheese (29.0%). Together,
these products contributed for 63.8% to the total dietary
calcium intake of this subgroup of adults. These were the
same foods as included in our previous, non-valid, calcium
intake list [18]. Mean portion sizes of the foods included in
the SCaIL were calculated using the mean portion sizes of
the 66 osteoporosis patients who were included in the
previous validation study [18]. To be able to calculate the
calcium intake, the calcium content of each portion was
calculated. Since the product groups in the SCaIL only
represent 63.8% of total dietary calcium intake, a rest
group was added to the SCaIL to reflect the amount of
calcium intake from other foods. The rest group represents
36.2% (100 - 63.8) of the mean total dietary calcium
intake of Dutch adults of 1040 mg [19]. This was rounded
off to 350 mg to be able to easily sum up the individual
calculations.
To be able to validate the SCaIL, an extensive DH with
specific focus on calcium-rich foods and extra attention for
assessment of portion sizes was performed as a reference
method, after completing the SCaIL. A DH is a commonly
used dietary assessment method to determine long-term,
usual dietary intake of patients. It is a reliable reference
method, since it takes into account day-to-day variation,
and determines individual foods, frequency of food
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consumption as well as portion sizes [21]. Furthermore, to
increase reliability, food consumption in a DH is asked per
meal. Although this meal-based DH requires more time,
patients can report their food consumption better per meal
than over an entire day [21]. The researcher (LR) who
performed all DHs in this study is also a dietician with
experience in conducting DHs and probing, which is
required to conduct a reliable DH. Since calcium was the
main parameter, specific attention on calcium-rich foods
was paid by performing a cross-check for these foods.
Moreover, to improve estimation of portion sizes, samples
of cups (100, 150, 220, 275, and 300 ml), glasses (100,
150, 200, 220, and 300 ml), bowls (100, 200, 250, and
450 ml) and slices of cheese (7, 10, 14, and 25 g) were
used. Conducting and processing a DH took about 90 min
per patient.
Beforehand, a difference of 250 mg calcium or more
between the SCaIL and the DH was determined as clini-
cally relevant. This amount was chosen because a differ-
ence of 250 mg/day or more may influence calcium
prescription that usually is provided in units of 500 mg
calcium.
Demographic and Clinical Characteristics
Demographic characteristics (age, gender, ethnicity,
weight, height), lifestyle characteristics (smoking status,
alcohol use), and disorder-related factors (previous clini-
cal fractures) were assessed during the appointment with
the researcher. From the medical charts, bone mineral
density of the lumbar spine and total hip of the most
recently performed dual-energy X-ray absorptiometry
were obtained, as well as information about the use of
medication and supplements. In addition, compliance of
prescribed calcium and vitamin D supplements and use of
extra ‘over the counter’ supplements on own initiative
were checked by asking for details about supplements
taken.
Statistical Analysis
Nutrient information of the DH was obtained using the
Dutch nutrient database of NEVO online (version 2013/4.0,
RIVM, Bilthoven, 2013) [22]. To calculate the amount of
calcium, the nutrient calculation program Compl-eat
(2010–2014 Human Nutrition, WUR, Wageningen, the
Netherlands) was used. Data were analyzed using SPSS for
Windows (IBM SPSS Statistics version 20, SPSS Inc.,
Chicago, IL, USA). Descriptive statistics were used to
calculate the means, frequencies and percentages. When
normally distributed, continuous data were compared using
an independent sample t test, and the Mann–Whitney U test
is used when data were not normally distributed. For cat-
egorical variables, a Chi-square test was used to compare
means. To compare the mean difference in calcium intake
between the SCaIL and the DH on group and individual
level, paired t tests and the Bland–Altman plot were used.
A one-sample t test was used to compare the mean calcium
intake with the RDA of calcium and with the intake of
Dutch adults in the Dutch National Food Consumption
Survey 2007–2010. If not normally distributed, nonpara-
metric tests were used instead of the t tests. Normally
distributed continuous data are reported as mean ± stan-
dard deviations. Data which were not normally distributed
are presented as median [interquartile range]. Categorical
data are presented as frequency (%). Sensitivity and
specificity were calculated, of the SCaIL compared to the
DH for identifying patients with a daily intake of 1000 mg
calcium or more and of 1200 mg calcium or more. Kappa
(r) was used to calculate the agreement between the SCaIL
and the DH to classify patients in the same category of
calcium intake: low (\1000 mg/day) or sufficient
(C1000 mg/day). As arbitrary benchmarks for the strength
of agreement, the following r values are used: r\ 0
reflects ‘poor’ agreement, r = 0–0.20 ‘slight,’ r =
0.21–0.40 ‘fair,’ r = 0.41–0.60 ‘moderate,’ r =
0.61–0.80 ‘substantial’ and r = 0.81–1 ‘almost perfect’
How many servings of the following products do you consume on a regular day?
[__] glasses of (butter)milk and other dairy drinks (250ml) x 300 mg =  [_____] mg
[__] bowls of yoghurt/quark/custard/pudding/porridge (200ml) x 250 mg =  [_____] mg
[__] servings of cheese (20g) x 300 mg =  [_____] mg
Calcium intake from other products                          =      350 mg
Total    =  [_____] mg
Fig. 1 SCaIL: short calcium
intake list to estimate daily
dietary calcium intake of
osteoporosis patients
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agreement [23]. p values \0.05 were considered to be
significant. The limits of agreement used for the Bland–
Altman analysis were defined as mean difference ±1.96
standard deviations of the difference.
Results
In this study, 66 patients were included, of whom 40
patients had primary osteoporosis and 26 patients sec-
ondary osteoporosis associated with a rheumatic disorder.
The demographic and clinical characteristics of the patients
are depicted in Table 1.
The mean ± SD dietary calcium intake was
1146 ± 440 mg/day by the SCaIL, and 1170 ± 485 mg/day
by the DH. Consequently, the mean difference ± SD
between both methods was 24 ± 350 mg/day, which was
non-significant (p = 0.568) and beforehand determined as
not clinically relevant (Table 2).
Although the mean difference between the SCaIL and the
DH was far smaller than 250 mg, a clinically relevant dif-
ference of 250 mg calciumormorewas observed in 33 out of
66 patients (50%). Out of these 33 patients, the SCaIL
underestimated calcium intake withC250 mg calcium in 19
patients (28.8%) and overestimated calcium intake with
C250 mg calcium in 14 patients (21.2%), compared to the
DH. A difference of C500 mg calcium was observed in 11
out of 66 patients (17%): the SCaIL underestimated calcium
intake with C500 mg calcium in 7 patients (10.6%) and
overestimated calcium intake with C500 mg calcium in 4
patients (6.1%), compared to the DH. These results are dis-
played as the Bland–Altman plot in Fig. 2. Sensitivity and
specificity of the SCaIL compared to the DH were 73 and
80%, respectively, for identifying patients with a daily intake
of 1000 mg calcium or more. For identifying patients with a
daily intake of 1200 mg calcium or more, sensitivity and
specificity of the SCaIL compared to the DH were 76 and
82%, respectively. The agreement between the SCaIL and
the DH to classify patients in the same category, low calcium
intake (\1000 mg/day) or sufficient calcium intake
(C1000 mg/day) was fair (r = 0.37).
The majority of patients (n = 52; 78.8%), had been
prescribed 500 mg/day of calcium supplements by their
treating physician. Of the remaining 14 patients, one
patient (1.5%) had a prescription of 400 mg/day, eight
patients (12.1%) had a prescription of 1000 mg/day and
five patients (7.6%) did not have any prescription at all.
Compliance to supplement prescription was on average
472 ± 218 mg/day. In addition, 15 patients used calcium
Table 1 Demographic and clinical characteristics
Total (n = 66)
Age (years) 65.8 ± 12.1
Female gender 57 (86.4)
Caucasian 59 (89.4)
Body mass index (kg/m2)a,c 24.4 [21.8–28.0]
Disease-related factors
Lumbar spine (T-score)a -1.76 ± 1.27
Total hip (T-score)b -1.41 ± 0.78
Clinical fractures[25 years of age 43 (65.2)
Data are reported as mean ± standard deviation, median [interquar-
tile range] or frequency (%)
a 1 primary osteoporosis patient missing; b 2 primary osteoporosis
patients missing; c 3 secondary osteoporosis patients missing
Fig. 2 Bland–Altman plot of the mean and difference in calcium
intake calculated using the dietary history method and the short
calcium intake list. The solid line represents the mean difference in
calcium intake (24.7 mg/day). The dotted lines are the limits of
agreement defined as ±1.96 standard deviations of the difference. In
dark gray, the area of clinically non-relevant difference in calcium
intake (-250 to 250 mg/day) is displayed. In light gray, the area of
500 mg/day difference in calcium intake is displayed
Table 2 Dietary calcium intake calculated using the SCaIL and using the dietary history method
Calcium intake via SCaIL (mg/day) Calcium intake via DH (mg/day) Difference (mg/day) p value
Total (n = 66) 1146 ± 440 1170 ± 485 24 ± 350 0.568
Primary osteoporosis (n = 40) 1173 ± 484 1220 ± 510 47 ± 346 0.391
Secondary osteoporosis (n = 26) 1104 ± 367 1094 ± 444 10 ± 359 0.884
Data are reported as mean ± standard deviation
DH dietary history, SCaIL short calcium intake list
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containing ‘over the counter’ supplements on own initia-
tive (mean in total population: 47 ± 143 mg/day). The
mean total daily calcium intake (nutrition plus (all) sup-
plements) amounted to 1689 ± 516 mg/day (Table 3).
This is significantly higher than the RDA of
1000–1200 mg/day of calcium (p\ 0.001). Four out of the
66 patients (6%) had a total daily calcium intake under the
RDA of 1000 mg/day. Furthermore, also the mean dietary
calcium intake of 1170 ± 485 mg calcium as assessed with
the DH was significantly higher than the mean dietary
calcium intake of healthy Dutch adults of 1040 mg
(p = 0.033). Forty out of the 66 patients (61%) had a
dietary calcium intake of 1000 mg or more and in addition
a prescription for calcium supplements. In total, 18 out of
the 66 patients (27.3%) had a total daily calcium intake
above the tolerable upper intake level of 2000 mg/day.
Discussion
The SCaIL is a three-item, quick and easy questionnaire to
estimate dietary calcium intake of osteoporosis patients at a
group level. Mean calcium intake calculated with the SCaIL
only differed 24 ± 350 mg/day of calcium with the DH,
which was used as a reference method. Although these
findings indicate that the SCaIL is a helpful tool to estimate
mean dietary calcium intake in groups of osteoporosis
patients, at an individual level a clinically relevant differ-
ence of 250 mg calcium or more was observed between the
SCaIL and the DH in around half of the patients. This makes
the SCaIL less useful for individual patients, because clin-
icians should be aware of not identifying a deficient calcium
intake less than 1000 mg/day in approximately 20% of the
patients and of prescribing supplements to patients with a
sufficient intake in approximately 30% of patients, accord-
ing to the sensitivity (80%) and specificity (73%) of the
SCaIL compared to the DH.
Inaccuracy of the 1-min SCaIL for calculating dietary
calcium intake in individual patients might most likely be
attributed to the limited number of items to be recorded:
Apparently, only three questions is not enough to be able to
accurately estimate dietary calcium intake of osteoporosis
patients. Since the three items in the SCaIL only represent
63.8% of total dietary calcium intake according to the
Dutch National Food Consumption Survey, a rest group
was added to reflect the amount of calcium intake from
other products. However, the question remains whether the
use of a standardized rest group is accurate (enough) to
estimate the remaining dietary calcium intake, or that more
detailed information on individual nutritional habits is
necessary. This last option suggests that a questionnaire
with more items would be more accurate. Indeed, existing
validated FFQs for calcium contain more food items.
However, as a consequence, it takes more time to fulfill
those questionnaires, while that amount of time is not
available in a doctor’s consulting room during busy clinical
practice.
There are some limitations of this study. First, we used a
commonly used dietary assessment method to calculate
dietary calcium intake, however, not the ‘gold standard.’
For example, a food diary with weighted portion sizes over
several days is considered to be a more accurate method to
assess nutritional intake [24]. Since this method is very
laborious and time-consuming for clinicians as well as
burdensome for the patients, and therefore not frequently
carried out on a large scale, we used a DH to calculate
dietary calcium intake instead of the weighted food diaries,
as a reference method to validate the SCaIL [21]. In this
case, a FFQ would not be a preferred reference method
since the SCaIL is a type of FFQ and assesses calcium
intake more or less in the same way and therefore shows
the same kind of errors [25]. Second, information bias
could have occurred during the DH, since patients tend to
give socially desirable answers, leading to a possible
overestimation of actual calcium intake. However, this
phenomenon is also likely to occur in other dietary
assessment methods. Third, this study included ‘only’ 66
patients. However, our number of inclusions is similar to
the numbers included in other recent studies validating
calcium intake questionnaires [15–17], and we do not
expect our results to be different if more patients were
included. Fourth, we did not take into account the possi-
bility that some of the patients do not use any dairy
products. In our study population, this was limited to one
patient. Food sources used by non-dairy consumers to
replace the calcium intake of dairy products are not
included in the SCaIL, since we especially looked at the
main contributors of calcium intake of the general Dutch
adult population to be able to focus on the general osteo-
porosis patient. Fifth, the total intake of calcium (nutrition
plus (all) supplements), does not necessarily reflect
intestinal calcium uptake, neither the amount of calcium
incorporated in the skeleton. There are many factors
Table 3 Total calcium intake divided into calcium intake through
diet, through taken prescriptions and through over the counter sup-
plements on own initiative
Total (n = 66)
Calcium intake
Diet (mg/day) 1170 ± 485
Prescribed supplements (mg/day) 472 ± 218
Over the counter supplements (mg/day) 47 ± 143
Total calcium intake (mg/day) 1689 ± 516
Data are reported as mean ± standard deviation
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affecting calcium metabolism, including intestinal calcium
absorption and vitamin D levels. However, the estimation
of intestinal or skeletal uptake of calcium is even more
sophisticated, and not feasible to investigate in this study.
Nevertheless, improvement in the estimation of dietary
calcium intake is important to be able to prescribe the
adequate amount of supplementation for more than one
reason. First, as mentioned before, too much calcium
supplementation possibly increases the risk of cardiovas-
cular events. Second, when using calcium supplements,
constipation, flatulence, diarrhea and nausea are regularly
encountered side effects as well.
Remarkably, mean dietary calcium intake in our popu-
lation is at the level of proposed current national and
international recommendations. The national guidelines of
the Dutch Institute for Health Care Improvement CBO [11]
recommend a RDA of 1000–1200 mg/day of calcium, as
do the international guidelines of the Institute of Medicine
[20], the International Osteoporosis Foundation [21] and
the National Osteoporosis Foundation [22]. In accordance
with these guidelines, our population had a mean daily
dietary calcium intake of 1170 ± 485 mg. Compared to
the mean dietary calcium intake of Dutch adults
(1040 mg/day [19]), the intake of our population is sig-
nificantly higher (p = 0.033). Forty out of the 66 patients
had a dietary calcium intake of 1000 mg or more and in
addition a prescription for calcium supplements. Possibly,
our patients are more aware of an adequate calcium intake
in order to optimally treat their osteoporosis. Nevertheless,
a considerably amount of patients (27.3%) had a total
calcium intake above the tolerable upper intake level of
2000 mg/day. Since too much calcium supplementation
may be associated with an increased risk of cardiovascular
events, this is clinically unwanted and indicates that a large
proportion of our osteoporosis patients might not even need
calcium supplementation, although more data are needed to
confirm this finding.
Conclusions
Although the SCaIL gives similar mean estimates of daily
dietary calcium intake at a group level, it is not a valid
method to estimate daily dietary calcium intake of indi-
viduals with osteoporosis. While aiming for enhanced
feasibility through simplicity, this tool is unreliable for its
intended purpose: the use in daily clinical practice in an
outpatient clinic. Therefore, we do not advise to use the
SCaIL in the consulting room of an outpatient clinic. More
extensive FFQs take more time than available to fulfill, but
as a result they provide a more accurate estimation of
dietary calcium intake. The challenge remains to develop a
new reliable calcium intake list with a balance between a
limited number of items and a high accuracy of estimating
dietary calcium intake. In the meantime, clinicians should
be aware that a large proportion of the osteoporosis patients
might not even need calcium supplementation because of a
sufficient dietary intake, and those patients might be at
increased risk of cardiovascular events while taking cal-
cium supplements.
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